The compound you described, **1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene**, is not a well-known or widely studied compound. There is no readily available information on its specific properties, synthesis, or applications in research.
It is possible that the compound is:
* **A novel compound**: It could have been synthesized in a specific research project, but not yet published or widely characterized.
* **A misnomer**: There might be a typo in the name, and it actually refers to a different, known compound.
* **Not a real compound**: The structure might not be chemically feasible.
**To find out more about this compound, you would need:**
* **The context in which it was mentioned**: Where did you encounter this compound name? This context might give clues about its purpose.
* **Additional information**: Do you know any details about its properties, synthesis, or potential applications?
* **Consult a chemist or researcher**: A specialist in organic chemistry or a relevant research field might be able to provide further insight.
Without more information, it's difficult to assess its importance for research.
1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3033896 |
| CHEMBL ID | 51887 |
| CHEBI ID | 189901 |
| MeSH ID | M0239821 |
| Synonym |
|---|
| CHEMBL51887 |
| 68684-63-9 |
| 4-[(1e)-1,2-diphenylbut-1-en-1-yl]phenol |
| CHEBI:189901 |
| 4-[(e)-1,2-diphenylbut-1-enyl]phenol |
| tamoxifen metabolite e |
| ec 614-707-2 |
| 1-hpdpb |
| ici 77949 |
| 4-(1,2-diphenyl-1-butenyl)phenol |
| 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene |
| 1-(4-hydroxyphenyl)-1,2-diphenylbut-1-ene |
| 1,2-diphenyl-1-(4-hydroxyphenyl)but-1-ene |
| 4-((e)-1,2-diphenylbut-1-enyl)phenol |
| phenol, 4-(1,2-diphenyl-1-butenyl)- |
| SL35001200 , |
| (e,z)-1,2-diphenyl-1-(4-hydroxyphenyl)-but-1-ene |
| phenol, 4-(1,2-diphenyl-1-butenyl)-, (e,z)- |
| niosh/sl3500120 |
| (e,z)-4-(1,2-diphenyl-1-butenyl)phenol |
| 4-(1,2-diphenylbut-1-en-1-yl)phenol |
| AKOS037652173 |
| 4-(1,2-diphenyl-1-buten-1-yl)phenol |
| phenol, 4-(1,2-diphenyl-1-buten-1-yl)- |
| A9V8JZM9A9 |
| (e)-1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene |
| (e,z)-4-(1,2-diphenylbut-1-en-1-yl)phenol |
| 69967-79-9 |
| (e)-4-(1,2-diphenyl-1-butenyl)phenol |
| 4-[(1e)-1,2-diphenyl-1-buten-1-yl]phenol |
| phenol, 4-[(1e)-1,2-diphenyl-1-buten-1-yl]- |
| Class | Description |
|---|---|
| stilbenoid | Any olefinic compound characterised by a 1,2-diphenylethylene backbone. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.85) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||